AVALON PHARMACEUTICALS INC Uncategorized Contracts & Agreements
73 Contracts & Agreements
- AMENDMENT NO. 2 (Filed With SEC on April 2, 2009)
- AMENDMENT NO. 1 (Filed With SEC on January 14, 2009)
- AVALON PHARMACEUTICALS, INC. (Filed With SEC on October 30, 2008)
- Amendment No. 1 to Rights Agreement (Filed With SEC on October 30, 2008)
- FORM OF CONTINGENT VALUE RIGHTS AGREEMENT (Filed With SEC on October 30, 2008)
- [LETTERHEAD] [LOGO] (Filed With SEC on May 4, 2007)
- [LETTERHEAD] [LOGO] May 2, 2007 (Filed With SEC on May 4, 2007)
- RIGHTS AGREEMENT Dated as of April 26, 2007 between AVALON PHARMACEUTICALS, INC. and AMERICAN STOCK TRANSFER & TRUST COMPANY 1 TABLE OF CONTENTS (Filed With SEC on April 30, 2007)
- Exhibit 10.11B (Filed With SEC on March 30, 2007)
- Exhibit 10.10 (B) (Filed With SEC on March 30, 2007)
- Exhibit 10.9B (Filed With SEC on March 30, 2007)
- Exhibit 10.8B (Filed With SEC on March 30, 2007)
- Exhibit 10.7B (Filed With SEC on March 30, 2007)
- Exhibit 10.6B (Filed With SEC on March 30, 2007)
- Exhibit 10.1 (Filed With SEC on August 2, 2006)
- Pilot Study Agreement (Filed With SEC on September 14, 2005)
- Avalon Pharmaceuticals, Inc. (Filed With SEC on September 9, 2005)
- develop our anticancer therapeutic candidates (Filed With SEC on June 23, 2005)
- develop our anticancer therapeutic candidates (Filed With SEC on June 23, 2005)
- develop our anticancer therapeutic candidates (Filed With SEC on May 3, 2005)
- develop our anticancer therapeutic candidates (Filed With SEC on May 3, 2005)
- develop our anticancer therapeutic candidates (Filed With SEC on May 3, 2005)
- develop our anticancer therapeutic candidates (Filed With SEC on May 3, 2005)
- develop our anticancer therapeutic candidates (Filed With SEC on May 3, 2005)
- develop our anticancer therapeutic candidates (Filed With SEC on May 3, 2005)
- develop our anticancer therapeutic candidates (Filed With SEC on May 3, 2005)
- develop our anticancer therapeutic candidates (Filed With SEC on May 3, 2005)
- develop our anticancer therapeutic candidates (Filed With SEC on May 3, 2005)
- develop our anticancer therapeutic candidates (Filed With SEC on May 3, 2005)
- develop our anticancer therapeutic candidates (Filed With SEC on May 3, 2005)
- develop our anticancer therapeutic candidates (Filed With SEC on May 3, 2005)
- develop our anticancer therapeutic candidates (Filed With SEC on May 3, 2005)
- develop our anticancer therapeutic candidates (Filed With SEC on May 3, 2005)
- develop our anticancer therapeutic candidates (Filed With SEC on May 3, 2005)
- develop our anticancer therapeutic candidates (Filed With SEC on May 3, 2005)
- develop our anticancer therapeutic candidates (Filed With SEC on May 3, 2005)
- develop our anticancer therapeutic candidates (Filed With SEC on May 3, 2005)
- develop our anticancer therapeutic candidates (Filed With SEC on May 3, 2005)
- develop our anticancer therapeutic candidates (Filed With SEC on May 3, 2005)
- develop our anticancer therapeutic candidates (Filed With SEC on May 3, 2005)